Lack of interactions between prenatal immune activation and Δ9-tetrahydrocannabinol exposure during adolescence in behaviours relevant to symptom dimensions of schizophrenia in rats

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 8:129:110889. doi: 10.1016/j.pnpbp.2023.110889. Epub 2023 Oct 31.

Abstract

The causality in the association between cannabis use and the risk of developing schizophrenia has been the subject of intense debate in the last few years. The development of animal models recapitulating several aspects of the disease is crucial for shedding light on this issue. Given that maternal infections are a known risk for schizophrenia, here, we used the maternal immune activation (MIA) model combined with THC exposure during adolescence to examine several behaviours in rats (working memory in the Y maze, sociability in the three-chamber test, sucrose preference as a measure, prepulse inhibition and formation of incidental associations) that are similar to the different symptom clusters of the disease. To this end, we administered LPS to pregnant dams and when the offspring reached adolescence, we exposed them to a mild dose of THC to examine their behaviour in adulthood. We also studied several parameters in the dams, including locomotor activity in the open field, elevated plus maze performance and their response to LPS, that could predict symptom severity of the offspring, but found no evidence of any predictive value of these variables. In the adult offspring, MIA was associated with impaired working memory and sensorimotor gating, but surprisingly, it increased sociability, social novelty and sucrose preference. THC, on its own, impaired sociability and social memory, but there were no interactions between MIA and THC exposure. These results suggest that, in this model, THC during adolescence does not trigger or aggravate symptoms related to schizophrenia in rats.

Keywords: Adolescence; Animal model; Maternal immune activation; Schizophrenia; THC.

MeSH terms

  • Animals
  • Behavior, Animal / physiology
  • Disease Models, Animal
  • Dronabinol / pharmacology
  • Female
  • Humans
  • Lipopolysaccharides
  • Memory Disorders / complications
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Rats
  • Schizophrenia*
  • Sucrose

Substances

  • Dronabinol
  • Lipopolysaccharides
  • Sucrose